wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38375284-B640ECE3-1F56-4ADC-9E58-B54BB6D3A0D1
Q38375284-B640ECE3-1F56-4ADC-9E58-B54BB6D3A0D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38375284-B640ECE3-1F56-4ADC-9E58-B54BB6D3A0D1
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.
P2860
Q38375284-B640ECE3-1F56-4ADC-9E58-B54BB6D3A0D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38375284-B640ECE3-1F56-4ADC-9E58-B54BB6D3A0D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5158fac8a61f84fbf48029ad860ed56adc7c4bbf
P2860
Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals.